Drawing First Blood

Drawing First Blood

Two experts to debate controversial topics in hematology and health care.

Clonal Hematopoiesis in Allogeneic Transplantation: Should It Influence Donor Selection?

Clonal hematopoiesis (CH), the presence of hematopoietic stem/precursor cells with somatic mutations, is a defining feature of hematologic malignancies. However, CH also occurs widely...

Are CAR T-Cell Therapies Worth the Costs?

Since the first chimeric antigen receptor (CAR) T-cell therapies gained FDA approval in 2017, the one-time treatments have led to unprecedented response rates in...

More Options, More Questions: Debating the Optimal Frontline Regimen for Multiple Myeloma

As part of the 2019 ASH Meeting on Hematologic Malignancies held September 6-7 in Chicago, experts were invited to discuss challenging patient care questions,...

Is Gun Control a Health Care Issue?

In October 2018, the American College of Physicians (ACP) clarified its stance on whether gun control should be treated as a public health issue:...
Alexis Thompson, MD, MPH and Thomas Coates, MD

Are New Treatment Options for Beta Thalassemia Ready for Widespread Use?

Patients with transfusion-dependent beta thalassemia, the most severe form of the disease, require lifelong management with red blood cell (RBC) transfusions, presenting a substantial...

In Myeloma, Cure or Control?

Over the past two decades, the U.S. Food and Drug Administration (FDA) has approved a number of new treatments for patients with myeloma –...

How Should We Treat Pregnant Women With Iron Deficiency?

Iron deficiency is prevalent among pregnant women, as maternal iron is used to supply the needs of the fetus and placenta, and additional iron...

Is Chronic Lymphocytic Leukemia Curable With Newer Agents?

Chronic lymphocytic leukemia (CLL) has long been considered an incurable disease. The goal of traditional frontline treatments is to minimize disease burden and allow...

Plasma or Recombinant Products for Hemophilia?

For the past half-century, plasma products have been the mainstay for the treatment of patients with hemophilia. In the 1950s, hematologists used large volumes...

Teaching Old Drugs New Tricks?

When the U.S. Food and Drug Administration (FDA) approved CPX-351 (a fixed combination of daunorubicin and cytarabine), it appeared that everything old was new...
Advertisement

Current Issue

November 2020 Bonus ASH Annual Meeting Preview Edition (Volume 6, Issue...

View issue flipbook November 2020 Bonus ASH Annual Meeting Preview Edition Volume 6, Issue 14This issue offers a behind-the-scenes look at this year's virtual annual meeting,...

Block title